Skip to content

Astrana Health ASTH Price / sales

Price / sales at other companies

CVS Health logo
CVS HealthCVS
0.2×0.0×
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
1.1×-0.4×
Agilon Health logo
Agilon HealthAGL
-0.3×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
0.6×+0.3×
Surgery Partners, Inc. logo
Surgery Partners, Inc.SGRY
0.5×-0.5×
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
0.7×-0.4×

Other financials

Income statement

See full
Revenue$965.1M+55.6%
Gross profit$105.7M+48.2%
Operating income$28.5M+38.6%
Net income$14.4M+116%
EPS (diluted)$0.29+107%

Balance sheet

See full
Cash & equivalents$478.4M+85.0%
Total debt$1.1B+136%
Total equity$800.3M+7.4%
Total assets$2.4B+77.2%

Cash flow

See full
Operating cash flow$68.1M+309%
CapEx$4.0M+30.3%
Free cash flow$64.1M+372%

Valuation

See full
Market cap$2.04B-3.0%
Enterprise value$2.63B+22.0%
P/E67.6×

Profitability

See full
Gross margin10.7%-1.3pp
Operating margin2.5%-1.1pp
Net margin0.9%
FCF margin4.6%

Returns & leverage

See full
Return on equity3.9%
Debt / equity1.3×+0.7×
Current ratio1.3×-0.4×

Where this comes from

Calculated from Astrana Health’s reported figures.

Based on the most recent quarter.

The official record: Astrana Health’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Astrana Health's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Astrana Health's price / sales?
Astrana Health (ASTH) reported price / sales of 0.4× in Q1 2026.
How has Astrana Health's price / sales changed year-over-year?
Astrana Health's price / sales decreased by 38.1% year-over-year, from 0.6× to 0.4×.
What is the long-term trend for Astrana Health's price / sales?
Over 5 years (2020 to 2025), Astrana Health's price / sales has grown at a -16.6% compound annual growth rate (CAGR), from 1× to 0.4×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.